DarioHealth (DRIO) Misses Q3 EPS by 277c

DarioHealth (NASDAQ: DRIO) reported Q3 EPS of ($2.96), $2.77 worse than the analyst estimate of ($0.19). Revenue for the quarter came in at $5 million versus the consensus estimate of $8.54 million.

For earnings history and earnings-related data on DarioHealth (DRIO) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• Capital One beats Q2 EPS by $1.13 as Discover integration gains pace